Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Matthias Hackl

Matthias Hackl

individual
Ecosystem influencer

About

Matthias Hackl is an Austrian biotechnology executive and RNA-biology specialist. He is CEO and co-founder of TAmiRNA, a Vienna biotech focused on microRNA biomarkers and precision-medicine diagnostics for age-associated diseases, and the company says he has led it since 2014. TAmiRNA also states that he co-founded RemuteBio in 2016 and has served as a scientific advisor to multiple biotech companies.

Areas of interest

microRNARNA biologyRNA biomarkersprecision medicinediagnosticsbiomarker discoverynext-generation sequencingsmall RNA sequencingextracellular vesiclesaginglongevityosteoporosiscardiovascular diseaseliver diseaseoncologybone and joint disorders